GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » Piotroski F-Score

Aker BioMarine ASA (OSL:AKBM) Piotroski F-Score : 4 (As of May. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aker BioMarine ASA Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Aker BioMarine ASA has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Aker BioMarine ASA's Piotroski F-Score or its related term are showing as below:

OSL:AKBM' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 8
Current: 4

During the past 12 years, the highest Piotroski F-Score of Aker BioMarine ASA was 8. The lowest was 3. And the median was 4.


Aker BioMarine ASA Piotroski F-Score Historical Data

The historical data trend for Aker BioMarine ASA's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA Piotroski F-Score Chart

Aker BioMarine ASA Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 3.00 3.00 7.00 4.00

Aker BioMarine ASA Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 6.00 4.00 4.00 4.00

Competitive Comparison of Aker BioMarine ASA's Piotroski F-Score

For the Packaged Foods subindustry, Aker BioMarine ASA's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aker BioMarine ASA's Piotroski F-Score Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Aker BioMarine ASA's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was -25.911 + 11.797 + 104.439 + -126.284 = kr-36 Mil.
Cash Flow from Operations was -159.787 + 217.711 + 498.987 + -15.918 = kr541 Mil.
Revenue was 956.561 + 1014.557 + 874.545 + 830.927 = kr3,677 Mil.
Gross Profit was 322.812 + 377.509 + 283.779 + 237.711 = kr1,222 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(8611.208 + 8849.809 + 8743.848 + 8725.409 + 8632.943) / 5 = kr8712.6434 Mil.
Total Assets at the begining of this year (Mar23) was kr8,611 Mil.
Long-Term Debt & Capital Lease Obligation was kr3,618 Mil.
Total Current Assets was kr3,063 Mil.
Total Current Liabilities was kr1,204 Mil.
Net Income was 146.217 + 47.372 + 1.976 + -185.368 = kr10 Mil.

Revenue was 715.489 + 699.255 + 780.528 + 727.782 = kr2,923 Mil.
Gross Profit was 299.257 + 321.307 + 314.187 + 220.125 = kr1,155 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(6841.933 + 7697.838 + 8203.626 + 8125.394 + 8611.208) / 5 = kr7895.9998 Mil.
Total Assets at the begining of last year (Mar22) was kr6,842 Mil.
Long-Term Debt & Capital Lease Obligation was kr3,583 Mil.
Total Current Assets was kr3,112 Mil.
Total Current Liabilities was kr1,189 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Aker BioMarine ASA's current Net Income (TTM) was -36. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Aker BioMarine ASA's current Cash Flow from Operations (TTM) was 541. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=-35.959/8611.208
=-0.00417584

ROA (Last Year)=Net Income/Total Assets (Mar22)
=10.197/6841.933
=0.00149037

Aker BioMarine ASA's return on assets of this year was -0.00417584. Aker BioMarine ASA's return on assets of last year was 0.00149037. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Aker BioMarine ASA's current Net Income (TTM) was -36. Aker BioMarine ASA's current Cash Flow from Operations (TTM) was 541. ==> 541 > -36 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=3617.665/8712.6434
=0.41522014

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=3583.088/7895.9998
=0.45378522

Aker BioMarine ASA's gearing of this year was 0.41522014. Aker BioMarine ASA's gearing of last year was 0.45378522. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=3062.652/1204.473
=2.54273197

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=3112.295/1189.097
=2.61736006

Aker BioMarine ASA's current ratio of this year was 2.54273197. Aker BioMarine ASA's current ratio of last year was 2.61736006. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Aker BioMarine ASA's number of shares in issue this year was 87.673. Aker BioMarine ASA's number of shares in issue last year was 88. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1221.811/3676.59
=0.3323218

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1154.876/2923.054
=0.39509226

Aker BioMarine ASA's gross margin of this year was 0.3323218. Aker BioMarine ASA's gross margin of last year was 0.39509226. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=3676.59/8611.208
=0.42695403

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=2923.054/6841.933
=0.42722634

Aker BioMarine ASA's asset turnover of this year was 0.42695403. Aker BioMarine ASA's asset turnover of last year was 0.42722634. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+1+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Aker BioMarine ASA has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Aker BioMarine ASA  (OSL:AKBM) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Aker BioMarine ASA Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Aker BioMarine ASA's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Aker BioMarine ASA (OSL:AKBM) Business Description

Traded in Other Exchanges
Address
Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA (OSL:AKBM) Headlines

No Headlines